446 related articles for article (PubMed ID: 30673768)
1. Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.
Minematsu A; Miyazaki T; Shimamura S; Nishikawa H; Nakayama H; Takazono T; Saijo T; Yamamoto K; Imamura Y; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2019; 14(1):e0210883. PubMed ID: 30673768
[TBL] [Abstract][Full Text] [Related]
2. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
3. Subunits of the vacuolar H+-ATPase complex, Vma4 and Vma10, are essential for virulence and represent potential drug targets in Candida albicans.
Kim SW; Park YK; Joo YJ; Chun YJ; Hwang JY; Baek JH; Kim J
Fungal Biol; 2019 Oct; 123(10):709-722. PubMed ID: 31542189
[TBL] [Abstract][Full Text] [Related]
4. Role of TFP1 in vacuolar acidification, oxidative stress and filamentous development in Candida albicans.
Jia C; Yu Q; Xu N; Zhang B; Dong Y; Ding X; Chen Y; Zhang B; Xing L; Li M
Fungal Genet Biol; 2014 Oct; 71():58-67. PubMed ID: 25220074
[TBL] [Abstract][Full Text] [Related]
5. Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Miyazaki T; Yamauchi S; Inamine T; Nagayoshi Y; Saijo T; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yanagihara K; Miyazaki Y; Kohno S
Antimicrob Agents Chemother; 2010 Apr; 54(4):1639-43. PubMed ID: 20100876
[TBL] [Abstract][Full Text] [Related]
6. The Vacuolar Ca
Luna-Tapia A; DeJarnette C; Sansevere E; Reitler P; Butts A; Hevener KE; Palmer GE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30728284
[TBL] [Abstract][Full Text] [Related]
7. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D
PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004
[TBL] [Abstract][Full Text] [Related]
8. Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs.
Zhang YQ; Gamarra S; Garcia-Effron G; Park S; Perlin DS; Rao R
PLoS Pathog; 2010 Jun; 6(6):e1000939. PubMed ID: 20532216
[TBL] [Abstract][Full Text] [Related]
9. Roles of VPH2 and VMA6 in localization of V-ATPase subunits, cell wall functions and filamentous development in Candida albicans.
Jia C; Zhang K; Zhang D; Yu Q; Zhao Q; Xiao C; Dong Y; Chu M; Li M
Fungal Genet Biol; 2018 May; 114():1-11. PubMed ID: 29522815
[TBL] [Abstract][Full Text] [Related]
10. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
11. Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
[TBL] [Abstract][Full Text] [Related]
12. Deletion of
Yu SJ; Chang YL; Chen YL
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311082
[No Abstract] [Full Text] [Related]
13. The putative vacuolar ATPase subunit Vma7p of Candida albicans is involved in vacuole acidification, hyphal development and virulence.
Poltermann S; Nguyen M; Günther J; Wendland J; Härtl A; Künkel W; Zipfel PF; Eck R
Microbiology (Reading); 2005 May; 151(Pt 5):1645-1655. PubMed ID: 15870472
[TBL] [Abstract][Full Text] [Related]
14. A Transcriptomics Approach To Unveiling the Mechanisms of
Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
[No Abstract] [Full Text] [Related]
15. Roles of vacuolar H+-ATPase in the oxidative stress response of Candida glabrata.
Nishikawa H; Miyazaki T; Nakayama H; Minematsu A; Yamauchi S; Yamashita K; Takazono T; Shimamura S; Nakamura S; Izumikawa K; Yanagihara K; Kohno S; Mukae H
FEMS Yeast Res; 2016 Aug; 16(5):. PubMed ID: 27370212
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
Nishikawa JL; Boeszoermenyi A; Vale-Silva LA; Torelli R; Posteraro B; Sohn YJ; Ji F; Gelev V; Sanglard D; Sanguinetti M; Sadreyev RI; Mukherjee G; Bhyravabhotla J; Buhrlage SJ; Gray NS; Wagner G; Näär AM; Arthanari H
Nature; 2016 Feb; 530(7591):485-9. PubMed ID: 26886795
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
18. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
[TBL] [Abstract][Full Text] [Related]
19. Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.
Samaranayake YH; Cheung BP; Yau JY; Yeung KW; Samaranayake LP
J Investig Clin Dent; 2011 May; 2(2):117-27. PubMed ID: 25426605
[TBL] [Abstract][Full Text] [Related]
20. Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole.
Siscar-Lewin S; Gabaldón T; Aldejohann AM; Kurzai O; Hube B; Brunke S
mBio; 2021 Jun; 12(3):e0112821. PubMed ID: 34061590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
